C12Y 115/01
Oxidoreductases acting on superoxide as acceptor: with nad or nadp as acceptor
Official title: with NAD or NADP as acceptor (1.15.1)
C12Y115/01 (Oxidoreductases acting on superoxide as acceptor: with nad or nadp as acceptor) appears on 175 US grants and 372 published applications in this corpus.
Search patents in C12Y- Granted patents
- 175
- Published applications
- 372
- Assignees
- 195
- Inventors
- 688
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 4 |
| 2003 | 1 | 5 |
| 2004 | 0 | 3 |
| 2005 | 1 | 3 |
| 2006 | 3 | 8 |
| 2007 | 1 | 8 |
| 2008 | 4 | 5 |
| 2009 | 2 | 3 |
| 2010 | 4 | 5 |
| 2011 | 4 | 4 |
| 2012 | 3 | 8 |
| 2013 | 1 | 6 |
| 2014 | 3 | 9 |
| 2015 | 5 | 8 |
| 2016 | 11 | 25 |
| 2017 | 3 | 16 |
| 2018 | 7 | 15 |
| 2019 | 12 | 24 |
| 2020 | 18 | 28 |
| 2021 | 9 | 21 |
| 2022 | 14 | 30 |
| 2023 | 10 | 33 |
| 2024 | 15 | 33 |
| 2025 | 15 | 38 |
| 2026 | 5 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Treatment of pathogen infections formulations and methods for use25 Aug 2026US 12,714,734 B2
- Tethering cysteine residues using cyclic disulfides18 Aug 2026US 12,709,745 B2Brandeis University
- RAAV-based compositions and methods for treating amyotrophic lateral sclerosis23 Jun 2026US 12,662,669 B2University of Massachusetts
- Paramyxovirus virus-like particles as protein delivery vehicles14 Apr 2026US 12,600,956 B2The Penn State Research Foundation
- Macrocyclic modulators of disease associated protein misfolding and aggregation24 Feb 2026US 12,559,863 B2Resq Biotech
- Puffed grain fermented enzyme having superoxide dismutase activity and catalase activity, production method therefor, and food composition comprising same1 Oct 2026US 2026/0293943 A1EcoMarine, LLC
- Uses of super-oxide dismutase supplements1 Oct 2026US 2026/0295019 A1
- Chemically-modified microorganism containing a superoxide dismutase mimic inorganic complex and use thereof for treating inflammatory diseases17 Sep 2026US 2026/0272998 A1
- RNAi Agents for Inhibiting Expression of Superoxide Dismutase 1 (SOD1), Compositions Thereof, and Methods of Use17 Sep 2026US 2026/0275351 A1Arrowhead Pharmaceuticals, Inc.
- Compositions and methods for treating amyotrophic lateral sclerosis17 Sep 2026US 2026/0275352 A1Voyager Therapeutics, Inc.
Most cited
By later US patents
- Expression using fused genes providing for protein product297US 4,751,180 AChiron Corporation · 1988
- Antioxidant preparation80US 5,922,346 AThione International, Inc. · 1999
- Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions51US 6,485,950 B1Council of Scientific and Industrial Research · 2002
- Targeting conjugates of albumin and therapeutic agents46US 4,749,570 AThe Governors of the University of Alberta · 1988
- Injection method and apparatus with electrical blood absorbing stimulation44US 4,832,682 ASurvival Technology, Inc. · 1989